104 related articles for article (PubMed ID: 20557364)
1. Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia.
Hassan C; Zullo A; Di Giulio E; Annibale B; Lahner E; De Francesco V; Ierardi E
Helicobacter; 2010 Jun; 15(3):221-6. PubMed ID: 20557364
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of early colonoscopy surveillance after cancer resection.
Hassan C; Pickhardt PJ; Zullo A; Di Giulio E; Laghi A; Kim DH; Iafrate F
Dig Liver Dis; 2009 Dec; 41(12):881-5. PubMed ID: 19467938
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of upper gastrointestinal endoscopy according to the appropriateness of the indication.
Di Giulio E; Hassan C; Pickhardt PJ; Zullo A; Laghi A; Kim DH; Iafrate F
Scand J Gastroenterol; 2009; 44(4):491-8. PubMed ID: 19031302
[TBL] [Abstract][Full Text] [Related]
4. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
[TBL] [Abstract][Full Text] [Related]
5. Endoscopic screening for gastric cancer.
Dan YY; So JB; Yeoh KG
Clin Gastroenterol Hepatol; 2006 Jun; 4(6):709-16. PubMed ID: 16765306
[TBL] [Abstract][Full Text] [Related]
6. A guide for surveillance of patients with Barrett's esophagus.
Provenzale D; Kemp JA; Arora S; Wong JB
Am J Gastroenterol; 1994 May; 89(5):670-80. PubMed ID: 8172136
[TBL] [Abstract][Full Text] [Related]
7. Cost effectiveness of colonoscopy, based on the appropriateness of an indication.
Hassan C; Di Giulio E; Pickhardt PJ; Zullo A; Laghi A; Kim DH; Iafrate F; Morini S
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1231-6. PubMed ID: 18995214
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of early one-year colonoscopy surveillance after polypectomy.
Hassan C; Pickhardt PJ; Di Giulio E; Kim DH; Zullo A; Morini S
Dis Colon Rectum; 2009 May; 52(5):964-71; discussion 971. PubMed ID: 19502863
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis between primary and secondary preventive strategies for gastric cancer.
Lee YC; Lin JT; Wu HM; Liu TY; Yen MF; Chiu HM; Wang HP; Wu MS; Hsiu-Hsi Chen T
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):875-85. PubMed ID: 17507609
[TBL] [Abstract][Full Text] [Related]
10. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.
Gerson L; Lin OS
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):319-25. PubMed ID: 17368231
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
12. The use of clinical, histologic, and serologic parameters to predict the intragastric extent of intestinal metaplasia: a recommendation for routine practice.
de Vries AC; Haringsma J; de Vries RA; ter Borg F; Nagtzaam NM; Steyerberg EW; van Dekken H; Kuipers EJ
Gastrointest Endosc; 2009 Jul; 70(1):18-25. PubMed ID: 19249770
[TBL] [Abstract][Full Text] [Related]
13. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding.
Tsoi KK; Lau JY; Sung JJ
Gastrointest Endosc; 2008 Jun; 67(7):1056-63. PubMed ID: 18407271
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of endoscopic surveillance of patients with gastric premalignant conditions.
Areia M; Dinis-Ribeiro M; Rocha Gonçalves F
Helicobacter; 2014 Dec; 19(6):425-36. PubMed ID: 25164596
[TBL] [Abstract][Full Text] [Related]
17. Screening for high-grade dysplasia in gastroesophageal reflux disease: is it cost-effective?
Soni A; Sampliner RE; Sonnenberg A
Am J Gastroenterol; 2000 Aug; 95(8):2086-93. PubMed ID: 10950062
[TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk.
Provenzale D; Schmitt C; Wong JB
Am J Gastroenterol; 1999 Aug; 94(8):2043-53. PubMed ID: 10445526
[TBL] [Abstract][Full Text] [Related]
19. Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions.
de Vries AC; Haringsma J; de Vries RA; Ter Borg F; van Grieken NC; Meijer GA; van Dekken H; Kuipers EJ
Helicobacter; 2010 Aug; 15(4):259-64. PubMed ID: 20633186
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
